Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Clinical trial NCT05721326 · COMPLETED

Trial details

NCT number: NCT05721326
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Genetic Predisposition to Disease Breast Cancer Female Ovarian Cancer Hereditary Breast and Ovarian Cancer Hereditary Cancer Syndrome Hereditary Diseases Gene Mutation-Related Cancer

Start date: 2023-05-01
Primary completion: 2025-12-31
Enrollment: 1283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.